SCHEMBL22456734

SCHEMBL22456734

CP(C)(=O)c1ccc(-c2ccc(-c3ccc4c5ccccc5c5nc6ccc7ccccc7c6n5c4c3)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
PTGES O14684 1/20 0.31
METAP2 P50579 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22456456 0.85 ALDH1A1 (0.46) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL22456496 0.85 ALDH1A1 (0.46) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL22456809 0.84 ALDH1A1 (0.42) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL22456454 0.83 ALDH1A1 (0.41) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL22456738 0.83 KDM4E (0.34) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL22456898 0.81 ALDH1A1 (0.38) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL22456742 0.80 TUBB4A (0.36) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL22457010 0.80 ALDH1A1 (0.43) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL22456805 0.78 ALDH1A1 (0.41) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19960506 0.78 ALDH1A1 (0.36) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200303661-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2020-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200303661-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME NR2E3, NR2E1, NOX1 KDM4E 2372/4885ALDH1A1 2038/4885HPGD 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.